BeiGene is a biopharmaceutical company that discovers, develops and commercialises medicines for cancer. Its portfolio centres on targeted therapies and immuno-oncology treatments, including medicines for blood cancers and solid tumours, which it supplies to hospitals and oncology specialists in China and other markets around the world. The company carries out research and development and manufacturing across sites in China and the United States, and it is based in Beijing, China, with substantial operations in Cambridge, Massachusetts.
BeiGene Ltd. trades under the code 688235 on the Shanghai Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #204 of 2280 on the Shanghai Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for China yet.
TrendStrong
86/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average-2.7%
From 52-week high-19.7%
MomentumFair
59/100
Typical recent returns for this exchange.
See the numbers →
3-month return-8.2%
6-month return7.0%
12-month, skipping last month-10.5%
Stability (higher is calmer)Fair
64/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)46.1%
Worst drawdown, 1 year (smaller is calmer)-33.6%
LiquidityStrong
94/100
Trades actively.
See the numbers →
Avg daily value traded1,166.40M CNY
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for China when fundamentals data for this market is added. All China stocks.
52-wk range 205.51 – 319.24Daily closes, split-adjusted
Signals
50-day average267.07
200-day average258.44
Golden/death cross (60d)Golden, 41 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)11.61
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Bearish
4 bullish · 1 neutral · 7 bearish
Monthly
Neutral
3 bullish · 1 neutral · 4 bearish
Moving averages (daily)
SMA 10
260.2
Bearish
EMA 10
261.7
Bearish
SMA 20
258.4
Bearish
EMA 20
260.4
Bearish
SMA 50
267.1
Bearish
EMA 50
261.8
Bearish
SMA 100
258.5
Bearish
EMA 100
260.8
Bearish
SMA 200
258.4
Bearish
EMA 200
258.4
Bearish
Oscillators (daily)
RSI (14)
44.99
Neutral
MACD (12, 26)
0.47
Bullish
Momentum (12)
0.83
Bullish
Stochastic %K (14)
32.35
Neutral
Williams %R (14)
-67.65
Neutral
CCI (20)
-7.94
Neutral
Pivot points (classic, last session)
S3
222.5
S2
236.7
S1
244.1
Pivot
258.4
R1
265.8
R2
280.0
R3
287.4
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CNY. Educational only, not financial advice.
